Pfizer beats earnings estimates as declining Covid business loses less revenue than expected
Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government.
OpenAI is working on AI education and safety initiative with Common Sense Media
OpenAI is partnering with Common Sense Media on an initiative to create AI guidelines and education materials for teens and families.
The stock market rally is showing signs of exhaustion, according to multiple chart analysts
A big week of earnings, economic reports and an FOMC meeting has the potential to roil markets that are already flashing some signs of exhaustion.
Microsoft CEO responds to AI-generated Taylor Swift fake nude images
CEO Satya Nadella said “guardrails” need to be placed around AI technology.
Forget a soft landing, there may be ‘no landing,’ economist says. Here’s what that would mean for you
The Fed is expected to announce no rate hike at the end of its two-day meeting. Now, the possibility of a ‘no landing’ scenario looks real, one economist says.
Tax filing season is here. What you need to know about itemizing, refunds and paying your bill
Jan. 29 marks the start of tax filing season. This is the first day you or your preparer can submit your 2023 return to the IRS. What to know before you do.
Biden administration discussing slowing some weaponry deliveries to Israel to pressure Netanyahu
U.S. is considering pausing or slowing some arms shipments to Israel to convince the government to heed U.S. calls to scale back its military assault in Gaza.
First-of-its-kind campaign fundraiser in the works with Bill Clinton, Barack Obama and Biden
The Biden campaign is planning a spring fundraiser for the president to appear with his two Democratic predecessors.
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Fast-approaching patent expirations will take a bite out of revenues and put the industry’s top players in the hot seat over the next few years.
